Browse the full record of transactions filed by 陈晨, Director. Officer active across 2 companies, notably 福达合金. In total, 65 reports have been recorded. Regulator: AMF. The full history is free.
Declarations 65 total
100,000 shares
SSE:273000000264513020 · 19 Mar 2026
Executives ● Sale神 神州泰岳 10 SZSE 4,590,000 shares
SZSE:173000008409332830 · 7 Jan 2025
Executives ● Purchase爱 爱尔眼科 11 SZSE 5,000 shares
SZSE:173000005689829440 · 15 Jul 2022
Ideal exit: 11 Apr 2023 (T+270) Executives ● Purchase爱 爱尔眼科 11 SZSE 5,000 shares
SZSE:173000005681551840 · 14 Jul 2022
Ideal exit: 10 Apr 2023 (T+270) Executives ● Purchase爱 爱尔眼科 14 SZSE 150,000 shares
SZSE:173000005649177630 · 1 Jul 2022
Ideal exit: 28 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 14 SZSE 54,700 shares
SZSE:173000005641036200 · 30 Jun 2022
Ideal exit: 27 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 114,400 shares
SZSE:173000005614950050 · 23 Jun 2022
Ideal exit: 20 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 200,000 shares
SZSE:173000005610978700 · 21 Jun 2022
Ideal exit: 18 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 150,000 shares
SZSE:173000005605692350 · 17 Jun 2022
Ideal exit: 14 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 99,500 shares
SZSE:173000005599321340 · 16 Jun 2022
Ideal exit: 13 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 15,000 shares
SZSE:173000005595967330 · 15 Jun 2022
Ideal exit: 12 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 10,000 shares
SZSE:173000005585460670 · 10 Jun 2022
Ideal exit: 7 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005581163970 · 9 Jun 2022
Ideal exit: 6 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005578660200 · 8 Jun 2022
Ideal exit: 5 Mar 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005564436580 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 18 SZSE 100,600 shares
SZSE:173000005564436540 · 1 Jun 2022
Ideal exit: 26 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 10,000 shares
SZSE:173000005560793300 · 31 May 2022
Ideal exit: 25 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 3,000 shares
SZSE:173000005555753570 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 1,000 shares
SZSE:173000005552239070 · 26 May 2022
Ideal exit: 20 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 4,000 shares
SZSE:173000005547832130 · 24 May 2022
Ideal exit: 18 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005545391140 · 23 May 2022
Ideal exit: 17 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 1,000 shares
SZSE:173000005542928000 · 20 May 2022
Ideal exit: 14 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 5,000 shares
SZSE:173000005522950560 · 12 May 2022
Ideal exit: 6 Feb 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005503421700 · 29 Apr 2022
Ideal exit: 24 Jan 2023 (T+270) Executives ● Purchase爱 爱尔眼科 21 SZSE 2,000 shares
SZSE:173000005491228640 · 28 Apr 2022
Ideal exit: 23 Jan 2023 (T+270) 25 of 65 declarations
Load more (40 remaining) About 陈晨 Chen Chen is a Board Member, Vice President, and Board Secretary at Fuda Alloy. He plays an essential role in the governance of the company and in strategic decision-making.